Research platform
Research platform of Noxi Lab allows generating original hybrid molecules from endogenous bioregulators, pharmacologically active compounds and nitric oxide donors (NO-donors)
Main News
* Magazine Kommersant published an article about promising multifunctional drug candidates of Gurus BioPharm * Gurus raises $0.7M for preclinical trials of a drug for asthma * Gurus raises $0.8M for preclinical trials of a drug for correction of cognitive disorders

Why to invest in biomedical innovations

Yield of investments in innovative drug development is 540% for 5 years 

Poliwogg Medical Breakthroughs Index

 

Investments in innovations from several sectors (Software, Tech Services, Healthcare, Telecom, Consumer Services) showed a yield of 400% for 7 years. It is lower than yield of biomedical innovation, but far ahead of all other indices

Thomson Reuters Venture Capital Indices